FY2025 · ended Dec 31, 2025 · Revenue $30.38M, -12.8% YoY · Filed Apr 1, 2026
Synergy CHC Corp. (SNYRQ) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $30.4 million and a net loss of $12.3 million. As of Mar 31, 2026 it held $292,115 in cash and investments and $25.1 million in total debt.
Revenue (TTM)
$27.70M
Net income (TTM)
$-15.79M
Operating cash flow (TTM)
$-3.81M
Free cash flow
$1.18M
+219.5% vs prior year
EPS (TTM)
$-1.52
Dividend per share
None
Shares outstanding
11.30M
+29.2% vs prior year
Net cash
$-24.83M
as of Mar 31, 2026
Operating margin
-39.6%
FY 2026
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- SNYRQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Westbrook, ME
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1562733
- Former names
- Synergy Strips Corp. (until Aug 6, 2015); Oro Capital Corporation, Inc. (until Apr 24, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2019 Dec 31, 2019 |
FY 2018 Dec 31, 2018 |
FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| Revenue | $30.4M | $34.8M | $29.4M | $33.8M | $35.6M |
| Operating income | -$8.5M | $5.8M | -$8.0M | -$4.9M | $1.8M |
| Net income | -$12.3M | $2.1M | -$9.2M | -$6.2M | $499,568 |
| Diluted EPS | -$1.27 | $0.28 | -$0.10 | -$0.07 | — |
| Operating cash flow | -$2.6M | -$4.8M | $2.9M | $1.3M | -$831,070 |
| Free cash flow | — | — | — | $1.2M | -$984,091 |
| Total assets | $10.2M | $16.3M | $5.2M | $20.0M | $24.0M |
| Total liabilities | $33.3M | $33.0M | $10.4M | $16.0M | $14.6M |
| Stockholders' equity | -$23.1M | -$16.6M | -$5.2M | $4.0M | $9.4M |
| Cash and investments | $2.6M | $687,920 | $1.2M | $459,736 | $2.0M |
| Total debt | $25.1M | $27.5M | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Sep 16, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Bankruptcy, Officer or director change
|
Sep 8, 2026 | Sep 4, 2026 |
| 8-K | Current report | Aug 26, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 21, 2026 | Aug 20, 2026 |
| 8-K | Current report | Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Other events
|
Jul 29, 2026 | Jul 15, 2026 |
All 252 Synergy CHC Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.